Eliane Ursula Wandeler

Title: Eliane Ursula Wandeler: Innovator in Dermatological Treatments

Introduction

Eliane Ursula Wandeler is a prominent inventor based in Kaiseraugst, Switzerland. She has made significant contributions to the field of dermatology through her innovative research and development of novel treatments for skin disorders. With a total of 2 patents, her work focuses on improving skin health and addressing various skin conditions.

Latest Patents

Wandeler's latest patents include a method for the treatment of skin disorders using dipeptide diaminobutyroyl benzylamide diacetate. This invention relates to a novel use of proline-containing dipeptides for the prevention and/or treatment of skin conditions associated with altered, damaged, or malfunctioning sebaceous glands. Another significant patent is for phosphinic peptide derivatives for use as MMP-12 inhibitors. This invention pertains to compounds that are selective inhibitors of Matrix Metalloprotease-12 (MMP-12), along with cosmetic and pharmaceutical compositions containing them, aimed at preventing and/or treating ailments associated with MMP-12.

Career Highlights

Eliane Wandeler is currently associated with Dsm IP Assets B.V., where she continues to advance her research in dermatological innovations. Her work has garnered attention for its potential impact on skin health and treatment methodologies.

Collaborations

Wandeler collaborates with notable colleagues, including Eileen Jackson and Remo Campiche, who contribute to her research endeavors and the development of her patented technologies.

Conclusion

Eliane Ursula Wandeler stands out as a key figure in the field of dermatological innovation, with her patents reflecting her commitment to enhancing skin health through scientific advancements. Her contributions are paving the way for new treatment options in dermatology.